Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
Year: 2002
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: University of Chicago
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
Award: Cancer Center Support Grant
OpenAlex ID: W2147478255